- 期刊
2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in Taiwan
摘要
Antiplatelet therapy is a key component in the treatment of acute coronary syndrome (ACS). The management of ACS has evolved considerably over recent years with the development of newand more potent antiplatelet agents. Clinical trials on ACS have demonstrated that potent antiplatelet agents can more effectively reduce cardiovascular events. However, there is a tipping point between safety and efficacy, beyond which the risk of bleeding and other adverse effects can outweigh the benefits of antiplatelet therapy. Striking a balance between safety and efficacy remains a major challenge. A consensus meeting of an expert panel composed of Taiwanese experts was held to provide recommendations for the management of adverse effects in patients with ACS receiving antiplatelet therapy. The common adverse effects of antiplatelet therapy include upper gastrointestinal bleeding, ecchymosis, hematuria, epistaxis and ticagrelor-related dyspnea. In this study, a literature review of these adverse events was performed and recommendations for the management were made.
延伸閱讀
- 陳惠芳、戴玫瑰（2017）。To Explore Disease Knowledge, Disease Attitude, Physical Symptom Distress and Self-Care Behaviors in Patients with Coronary Artery Disease: An Example from a Medical Center in Southern Taiwan。高雄護理雜誌，34(2)，14-27。https://doi.org/10.6692/KJN-2017-34-2-2
- 侯美夙（2008）。The Medical Quality and Resource Utilization of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Taiwan.〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-1707200816215800
- Wu, Y. W., & Chen, J. W. (2019). Risk factor control and medical therapy of coronary artery disease in Taiwan - Review and Recommendations - Part III: Blood sugar management for patients with coronary artery disease. 海峽循環醫學雜誌, 1(3), 14-16. https://doi.org/10.6907/SCJ.201911_1(3).0003
- Li, Y. H., Chao, T. H., Liu, P. Y., Ueng, K. C., & Yeh, H. I. (2018). Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients. Acta Cardiologica Sinica, 34(5), 371-378. https://doi.org/10.6515/ACS.201809_34(5).20180629A
- Huang, C. C., & Chen, J. W. (2019). Risk factor control and medical therapy of coronary artery disease in Taiwan - Review and Recommendations - Part II: Blood pressure management for patients with coronary artery disease. 海峽循環醫學雜誌, 1(3), 9-13. https://doi.org/10.6907/SCJ.201911_1(3).0002